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           By contributing to the positioning of immuno-
competent cells throughout the body, leukocyte 
migration plays a central role in the function of 
the immune system. Extravasation of blood 
leukocytes is critical for immune surveillance 
and is a crucial step in the development of 
  infl   ammatory responses. During migration, 
in  tegrins mediate leu  kocyte adhesion to the 
extracellular matrix or other cells and function 
as traction sites over which leukocytes migrate. 
Integrins are a family of            het  erodimeric 
membrane receptors that mediate cell  –  cell, 
cell  –  extracellular matrix, and cell  –  pathogen inter-
actions. The integrin LFA-1 (or        L         2  ) is ex-
pressed on most leukocytes and plays a major 
role in regulating leukocyte adhesion and re-
cruitment to damaged or infected tissues dur-
ing infl  ammation. 
  Extracellular signals such as chemokines 
stimulate G protein  –  coupled receptors and their 
associated signaling cascades (  “  inside-out  ”  sig-
nals), resulting in dramatic changes in cell shape 
and eventually leukocyte polarization. Polarized 
leukocytes exhibit dynamic spatio-temporal 
regu  lation of intracellular signaling events and 
cytoskeletal rearrangement. Precise spatial and 
temporal regulation of integrin activation occurs 
during the directional migration of these cells. 
The process of leukocyte migration can be con-
ceptualized as a cyclic process that involves at 
least three interdependent events, including de 
novo cell adhesion at the leading edge, cell con-
traction at the cell body, and detachment at the 
trailing edge. Active integrins mediate adhe-
sion at the leading edge to provide traction, and 
de-adhesion by inactive integrins takes place at 
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  Precise spatial and temporal regulation of cell adhesion and de-adhesion is critical for 
dynamic lymphocyte migration. Although a great deal of information has been learned 
about integrin lymphocyte function  –  associated antigen (LFA)-1 adhesion, the mechanism 
that regulates effi  cient LFA-1 de-adhesion from intercellular adhesion molecule (ICAM)-1 
during T lympho  cyte migration is unknown. Here, we show that nonmuscle myosin heavy 
chain IIA (MyH9) is recruited to LFA-1 at the uropod of migrating T lymphocytes, and 
inhibition of the association of MyH9 with LFA-1 results in extreme uropod elongation, 
defective tail detachment, and decreased lymphocyte migration on ICAM-1, without 
affecting LFA-1 activation by chemokine CXCL-12. This defect was reversed by a small 
molecule antagonist that inhibits both LFA-1 affi  nity and avidity regulation, but not by an 
antagonist that inhibits only affi  nity regulation. Total internal refl  ection fl  uorescence 
microscopy of the contact zone between migrating T lymphocytes and ICAM-1 substrate 
revealed that inactive LFA-1 is selectively localized to the posterior of polarized T lympho-
cytes, whereas active LFA-1 is localized to their anterior. Thus, during T lymphocyte migra-
tion, uropodal adhesion depends on LFA-1 avidity, where MyH9 serves as a key mechanical 
link between LFA-1 and the cytoskeleton that is critical for LFA-1 de-adhesion. 196 LFA-1 DE-ADHESION | Morin et al.
low affi   nity state. Whereas, XVA143 inhibits only affi   nity 
regulation activation, suggesting that avidity regulation does 
not require conformational change in response to signals from 
within the cell, but still requires conversion of the      L I domain 
to the high affi   nity and open conformation driven by ICAM-1 
binding (  16  ). Therefore, these reagents are excellent tools for 
distinguishing between affi   nity and avidity regulation of LFA-1 
adhesiveness during cell migration. 
  Myosins are actin-dependent molecular motors that use 
the energy of ATP hydrolysis to move along actin fi  laments. 
The myosin family consists of at least 20 structurally and 
functionally distinct classes (  22  ). Myosin heavy chains typi-
cally consist of three distinct regions, including an N-terminal 
motor or head domain responsible for actin binding and ATP 
hydrolysis, a neck region that binds light chains or calmodulin, 
and a C-terminal tail that is responsible for cargo binding and/
or dimerization of heavy chains. The myosin II family can be 
divided into nonmuscle cytoplasmic, cardiac muscle, smooth 
muscle, and skeletal muscle subclasses, each with multiple 
isoforms (  23  ). Myosin II in nonmuscle cells plays important 
roles in cytokinesis and cell migration (  24  ). In   Dictyostelium  , 
myosin II gene knockout reduces migration speed and re-
sults in a loss of forward bias in protrusion (  25  ). Genomic 
analysis has identifi  ed at least three diff  erent nonmuscle myo-
sin heavy chain type II isoforms in humans termed nonmuscle 
myosin heavy chain IIA (MyH9), nonmuscle myosin heavy 
chain IIB (MyH10), and nonmuscle myosin heavy chain IIC 
(MyH14) (  23  ). Most cell types contain both MyH9 and MyH10. 
However, some are selectively enriched either in MyH9 
(e.g., platelets, lymphocytes, neutrophil granulocytes, brush 
border cells, and RBL2H3 cells) (  26  ) or in MyH10 (e.g., 
neurons) (  27  ). Here, we provide evidence that adhesion of the 
tail of migrating T lymphocytes is mediated by avidity-regulated 
LFA-1 and that MyH9 plays a key role in LFA-1 de-adhesion 
and tail retraction. 
    RESULTS   
  ICAM-1 binding recruits MyH9 to LFA-1 
  To identify key cytoplasmic molecules mediating LFA-1  –  de-
pendent T lymphocyte migration on ICAM-1, LFA-1 immuno-
precipitates obtained from human primary T lymphocytes 
adherent to four diff  erent substrate conditions were analyzed 
(  Fig. 1  ).   First, T lymphocytes were exposed to Mg  2+  /EGTA 
and, thus, cell surface LFA-1 was constitutively active. Both on 
poly-  l   lysine and on ICAM-1 surfaces, T lymphocytes spread 
out, but no polarization or migration was observed (  Fig. 1 A   
and Videos S1 and S2, which are available at http://www.jem
.org/cgi/content/full/jem.20071543/DC1). This suggests that 
LFA-1/ICAM-1 binding (  “  outside-in  ”   signal) is not suffi   cient 
to induce cell polarization and migration. Next, when T lympho-
cytes were placed on a poly-  l   lysine/CXCL-12 surface in buff  er 
with Ca  2+  /Mg  2+  , cell polarization became obvious, although no 
signifi  cant cell migration was detected (  Fig. 1 A   and Video S3). 
On ICAM-1/CXCL-12  –  coated surfaces, T lymphocyte 
polarization was more evident as seen by membrane ruffl   ing 
at the leading edge and contraction of the opposing edge 
the trailing edge to allow for leukocyte detachment and forward 
movement (  1  ). Therefore, both integrin-mediated cell adhe-
sion and de-adhesion are essential for effi   cient cell migration. 
  Several components of the inside-out signaling path-
ways involved in the regulation of LFA-1 adhesiveness have 
been identifi  ed. After being freed from the rod domain by 
proteolysis or truncation, talin head domain activates inte-
grins by directly binding to       subunits (  2  –  5  ). Mutant talin 
resistant to calpain proteolysis reduces adhesion turnover 
during cell migration (  6  ). Rap-1, a member of Ras family of 
small GTPases, and its interacting molecule, RAPL, medi-
ate TCR- and chemokine-induced adhesion of leukocytes to 
intercellular adhesion molecule (ICAM)-1 and vascular cell 
adhesion molecule 1 (  7, 8  ). Although an extensive amount of 
information has been gathered from the intensive investiga-
tion of integrins, most studies have focused on the signaling 
processes associated with integrin activation and cell adhesion. 
However, the mechanisms for integrin inactivation or de-
adhesion during cell migration are equally important and re-
main uncharacterized. 
  LFA-1 ligand binding activity is controlled by two dis-
tinct mechanisms,   “  affi   nity  ”   regulation and   “  avidity  ”   (or   “  va-
lency  ”  ) regulation. In the former, conformational changes in 
the protein impart high affi   nity ligand binding. In the latter, 
membrane redistribution of LFA-1 functions to strengthen 
overall cellular adhesiveness. During inside-out signaling, 
stimuli received by a variety of cell surface receptors initiate 
intracellular signaling that impinges upon integrin cytoplas-
mic domains and disassociates the cytoplasmic tails of        L   and        2   
subunits (  2, 9  –  11  ). These events lead to disruption of the 
association between the integrin head and legs (  10, 12  ). The 
resultant switchblade-like opening of the integrin molecule is 
linked to the active high affi   nity conformation that binds 
extrinsic ligands such as ICAMs (  13  –  15  ). In addition to altera-
tions in the conformation of individual integrin            hetero-
dimers, the overall strength of cellular adhesive interactions 
is also regulated by the total number of bonds formed (  16  ). 
The number of adhesive bonds that can form is mainly mediated 
by changes in the cell surface receptor diff  usivity or local 
clustering, and ligand binding  –  dependent redistribution as a 
consequence of adhesion strengthening (  8, 13, 16  –  21  ). Although 
LFA-1 affinity and avidity is thought to be tightly and dy-
namically regulated during T lymphocyte migration, the rela-
tive importance of the diff  erent states of integrin activation 
during cell migration remains unknown. Recently, we have 
assessed the eff  ects of two distinct classes of small molecule 
allosteric LFA-1 antagonists on LFA-1 regulation (  16  ). The 
      I allosteric antagonist, BIRT377, binds to the        L   I domain 
and stabilizes it in the low affi   nity closed conformation. In 
contrast, the      /      I  –  like allosteric antagonist, XVA143, binds 
to the metal-ion  –  dependent adhesion site of the        2   I  –  like do-
main and also, in part, to the        L   subunit. XVA143 blocks the 
communication of conformational signals from the        2   I  –  like 
domain to the        L   I domain; therefore, it blocks inside-out 
affi   nity enhancement (  16  ). BIRT377 inhibits both affi   nity and 
avidity regulation of LFA-1 by stabilizing the I domain in the JEM VOL. 205, January 21, 2008 
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expressed both MyH9 and MyH10, but not MyH14 (  Fig. 1 D  ). 
Mass spectrometric analysis of LFA-1 immunoprecipitates did 
not provide any evidence of an association between MyH10 
and LFA-1. To confi  rm that the 220-kD protein was, in fact, 
MyH9, Western blot analysis with an anti-MyH9 antibody was 
performed. As can be seen in   Fig. 1 E  , the association of MyH9 
with LFA-1 was most apparent in T lymphocytes bound to 
ICAM-1 in the presence of Mg  2+  /EGTA, but it could also 
be seen in cells migrating on ICAM-1/CXCL-12 surfaces 
(  Fig. 1 E  ). Notably, MyH9 association with LFA-1 always 
coincided with      -actin association (  Fig. 1, B and E  ). 
  MyH9 mediates LFA-1 de-adhesion at the uropod 
  To analyze the intracellular distribution of MyH9 during 
LFA-1  –  mediated T lymphocyte migration, primary human T 
lymphocytes were transfected with GFP-tagged MyH9 (MyH9-
GFP). Time-lapse fluorescence microscopy revealed that 
MyH9 was enriched in the uropod during migration, whereas 
     -actin was predominantly situated at the leading edge (  Fig. 2 A   
and Videos S5 and S6, which are available at http://www
.jem.org/cgi/content/full/jem.20071543/DC1).   Although 
the uropodal distribution of MyH9 during migration hinted at 
a possible role for MyH9 in tail retraction, it was unclear if 
a direct relationship existed between MyH9 and LFA-1 de-
adhesion. To investigate this further, we used the highly spe-
cifi  c inhibitor of class II myosin ATPase activity, blebbistatin 
(  28, 29  ). Treatment of T lymphocytes with blebbistatin pre-
vented MyH9 association with LFA-1 (  Fig. 2 D  ). Surprisingly, 
blebbistatin treatment resulted in a nonphysiological, extremely 
polarized cell morphology, in which the uropod was extended 
in length (  Fig. 2, B   and C, and Video S7). In stark contrast, 
the majority of control (DMSO-treated) cells were polarized 
with relatively short tails (  Fig. 2, B   and C, and Video S8). 
  The fi  nding that blebbistatin induces extreme elongation 
of the uropod suggests that it may suppress T lymphocyte mi-
gration by preventing LFA-1 de-adhesion at the uropod. To 
test this hypothesis, we performed live-cell imaging of T lym-
phocyte migrating on ICAM-1/CXCL-12  –  coated glass sur-
faces. Quantitative analysis revealed that blebbistatin signifi  cantly 
decreased the lateral random migration of T lymphocytes on 
ICAM-1 (  Fig. 2, E   and F). 
  To confi  rm the results obtained with blebbistatin and to 
further assess the specifi  city of MyH9 in regulating LFA-1 de-
adhesion, small interfering RNA (siRNA)-mediated knock-
down of MyH9 expression was performed. As shown in   Fig. 
3 C  , siRNA selective for MyH9 (  30  ) successfully reduced the 
protein expression level in human T lymphocytes.   Similar to 
blebbistatin, MyH9 siRNA elicited abnormal uropodal ex-
tension (  Fig. 3, A   and B). 
  MyH9 is not required for LFA-1 activation 
  The observation that MyH9 is mainly localized at the uropod 
and mediates LFA-1 de-adhesion from ICAM-1 does not 
preclude its functioning in initial cell adhesion to ICAM-1 
and in LFA-1 activation at the leading edge during cell 
migration. To test whether MyH9 association with LFA-1 
to form the trailing edge (  Fig. 1 A   and Video S4). Unlike cells 
on poly-  l   lysine/CXCL-12 surface, these T lymphocytes ac-
tively migrated. 
  Analysis of LFA-1 immunoprecipitates from the adherent 
or migrating human T lymphocytes revealed that a promi-
nent protein of ~220 kD was selectively associated with LFA-1 
under conditions where T lymphocytes were bound to ICAM-1 
in the presence of Mg  2+  /EGTA (  Fig. 1 B  ). This polypeptide 
could not be detected in LFA-1 immunoprecipitates obtained 
from poly-  l   lysine  –  bound T lymphocytes. The 220-kD species 
was identifi  ed to be MyH9, as determined by mass spectrometry 
(  Fig. 1 C  ). RT-PCR revealed that human T lymphocytes 
    Figure 1.         Association of MyH9 with LFA-1.   (A) Human primary T 
lymphocytes were allowed to adhere to cover glasses coated with ICAM-1 
(IC-1) or poly-  L   lysine (PLL)   ±   CXCL-12. Cells were suspended in either 
L-15/2 mg/ml glucose or 20 mM Hepes, 150 mM NaCl, 5 mM MgCl  2  , 1 mM 
EGTA, and 2 mg/ml glucose, as indicated. Migrating T lymphocytes were 
tracked over a 20-min period, and time-lapse DIC images were acquired 
every 5 s to generate movies (Videos S1  –  4). The bottom left corner of 
each image shows a randomly selected region at threefold magnifi  cation. 
Bar, 100   μ  m. (B and C) LFA-1 immunoprecipitates obtained from bound 
cells (using TS2/4 antibody) were analyzed for possible LFA-1 binding 
partners. MyH9 was identifi  ed by silver staining (  n   = 3) (B) and mass 
spectrometry (C). The spectrum of one of the MyH9 peptides obtained by 
nanospray-ion trap tandem mass spectrometry is shown in C. (D) PCR 
amplifi  cation of MyH9, MyH10, and MyH14 cDNAs from human PBMCs 
and T lymphocytes. Reverse-transcribed cDNA from human skeletal mus-
cle served as a positive control. (E) LFA-1 immunoprecipitates obtained for 
each of the four substrate conditions were subjected to Western blotting 
with the indicated antibodies.     198 LFA-1 DE-ADHESION | Morin et al.
Accordingly, binding of KIM127 to T lymphocytes in cell sus-
pension signifi  cantly increased 5 min after adding CXCL-12, 
whereas the binding was undetectable at points beyond 20 min 
(  Fig. 4 A  ).   Rapid and transient LFA-1 activation was confi  rmed 
in cell adhesion assays, where T lymphocyte adhesion on im-
mobilized ICAM-1 was signifi  cantly enhanced after 2 min of 
soluble CXCL-12 stimulation and rapidly down-regulated 
within 5  –  10 min (  Fig. 4 B  ), and in a fl  ow chamber assay, where 
T lymphocytes arrest on immobilized ICAM-1 and CXCL-12 
triggered by LFA-1 activation occurs within 1 s under fl  ow 
(  Fig. 4 E  ). Therefore, stimulation of human primary T lym-
phocytes with CXCL-12 induces a rapid and transient LFA-1 
activation that peaks within a few seconds after activation. 
  During rapid LFA-1 activation by CXCL-12, no signifi  -
cant association of MyH9 with LFA-1 was observed (  Fig. 4 C  ). 
MyH9 and LFA-1 association occurred later, at ~20 min 
after CXCL-12 stimulation (  Fig. 4 C  ). All leukocytes that ex-
press LFA-1 also express one or more of its ligands, facilitating 
the formation of aggregates of homotypically adherent cells (  16  ). 
Therefore, the late association of MyH9 with LFA-1 may be 
due to LFA-1 and ICAM-1 binding through homotypic T 
lymphocyte interaction in the cell suspension. Inhibition of 
MyH9 with blebbistatin had no eff  ect on LFA-1 activation 
by CXCL-12 (  Fig. 4, D and E  ). The results suggest that MyH9 
recruitment to LFA-1 does not precede or coincide with 
LFA-1 activation. 
occurs before LFA-1 activation and possibly mediates LFA-1 
activation, the kinetics of CXCL-12  –  induced LFA-1 activa-
tion were measured by fl  ow cytometric analysis of KIM127 
labeling. KIM127 is an activation-dependent monoclonal 
antibody; it recognizes a portion of the        2   EGF2 domain that 
is buried in the bent, inactive conformation and exposed in the 
extended, active conformation. Unlike the continuous re-
generation of active LFA-1 during cell migration, chemo-
kines elicit transient LFA-1 activation in suspended cells (  31, 32  ). 
    Figure 3.         Selective suppression of MyH9 protein with siRNA.   Human 
primary T lymphocytes were transfected with Cy3-conjugated control siRNA 
only or Cy3-conjugated control siRNA plus MyH9 siRNA at a 1:10 ratio 
and allowed to migrate on ICAM-1/CXCL-12 cover glasses. (A) An overlay 
of DIC and Cy3 fl  uorescence images is shown. Bar, 20   μ  m. (B) Quantifi  cation 
of tail detachment, as determined by the polarization index. The polariza-
tion index was measured on Cy3  +   cells. *, P   <   0.0001 for MyH9 siRNA 
(  n   = 19) versus control siRNA only. (C) T lymphocyte cell lysates were ana-
lyzed for MyH9 and      -actin levels by Western blot. Experiments were 
repeated on T lymphocyte preparations from three independent donors.          Figure 2.         MyH9 mediates LFA-1 de-adhesion at the uropod.   (A)  Human 
T lymphocytes were transfected with MyH9-GFP or     -actin – GFP,  and 
cell migration on ICAM-1 and CXCL-12 was analyzed by time-lapse 
fl  uorescence microscopy at 37  °  C (see also Video S5 for MyH9-GFP and 
Video S6 for      -actin  –  GFP). Arrows mark the direction of migration. Two-
dimensional images and three-dimensional histograms of fl  uorescence 
intensity and cell surface distribution are shown in a pseudo-color scale 
(from low [black] to high [red]). Bar, 20   μ  m. (B and C) Human T lymphocytes 
were pretreated with DMSO or 50      M blebbistatin and allowed to migrate 
on ICAM-1  –   and CXCL-12  –  coated cover glass for 20 min at 37  °  C (B). 
The polarization index of cells was calculated as the ratio of x to y, where x 
is the longest distance across cells (from head to tail) and y is the greatest 
width perpendicular to x (C). Bar, 25   μ  m (B). (D) T lymphocytes were pre-
treated with DMSO or 50      M blebbistatin for 2 h and stimulated with 
CXCL-12 for 20 min. LFA-1 immunoprecipitates (TS2/4 antibody) were then 
obtained and subjected to silver staining. (E and F) Human T lymphocytes 
were pretreated with DMSO or 50      M blebbistatin for 1 h at 37  °  C, and cell 
migration on ICAM-1/CXCL-12  –  coated cover glasses was tracked over a 
30-min period. Each line represents one cell. Experiments were repeated 
on T lymphocyte preparations from three independent donors.     JEM VOL. 205, January 21, 2008 
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insensitive monoclonal antibody, TS2/4, was used to measure 
total LFA-1. TS2/4 labeling revealed that LFA-1 molecules 
were broadly distributed on T lymphocytes migrating on 
ICAM-1 substrate in response to CXCL-12 (  Fig. 5 A  ).   AL-57 
labeling was mainly present at the leading edge of migrating 
T lymphocytes under control conditions (  Fig. 5 A  ). The re-
stricted distribution of AL-57 labeling at the leading edge was 
not signifi  cantly altered by blebbistatin treatment (  Fig. 5 A  ). 
  Periodic lamellipodial contraction at the leading edge is 
often seen in spreading and migrating cells (  36  ). We analyzed 
the periodic contraction of the protruding leading edge by 
creating kymographs using diff  erential interference contrast 
(DIC) microscopy (  Fig. 5 B  ). In control cells, a single cycle of 
the contraction, defi  ned as a protrusion followed by a retraction 
(white arrows), had a period of ~10 s. The time interval between 
each contraction was not signifi  cantly altered by blebbistatin 
(  Fig. 5 B   and Video S9, which is available at http://www
.jem.org/cgi/content/full/jem.20071543/DC1). These results, 
collectively with the fi  nding that MyH9 association is not 
required for LFA-1 activation and blebbistatin does not 
aff  ect localization of active high affi   nity LFA-1 at the leading 
edge of migrating T lymphocytes, suggest that MyH9 is dis-
pensable for LFA-1 activation and de novo cell adhesion at the 
leading edge. 
  Although highly specifi  c to myosin II, treatment of cells 
with 50      M blebbistatin only partially inhibits nonmuscle 
myosin heavy chain II functions (  37  ). In addition, periodic 
retractions of the lamellipodia are induced by myosin light 
chain kinse  –  dependent, but Rho-associated kinase (ROCK)-
independent, force generation by myosin II (  36  ). To investi-
gate whether the contractile oscillations at the leading edge 
and the retraction at the uropod are diff  erentially sensitive to 
blebbistatin, we tested a range of blebbistatin concentrations. 
Unlike a 50-     M concentration, treatment of T lymphocytes 
with 200      M blebbistatin abolished the periodic lamellipodia 
retraction (  Fig. 5 B  ) and dramatically reduced the uropod 
elongation (  Fig. 5 C  ). Therefore, MyH9 at the uropod ap-
pears to be more susceptible to inhibition by blebbistatin than 
at the leading edge of migrating T lymphocytes. 
  Affi  nity- and avidity-regulated LFA-1 mediates adhesion
at the anterior and at the posterior of migrating
T lymphocytes, respectively 
  Both affi   nity regulation and avidity regulation govern the 
strength of integrin  –  ligand adhesiveness (  38  ). The relative 
importance of the integrin activation states in cell migration 
remains unknown, but is thought to vary during the cell mi-
gration process. To investigate the spatial organization of 
  affi   nity and avidity regulation of LFA-1 during T lymphocyte 
migration, we used two classes of LFA-1 small molecule an-
tagonists, the       I allosteric antagonist, BIRT377, and the 
     /      I  –  like allosteric antagonist, XVA143. Because of their 
diff  erent modes of action (refer to Introduction),       I alloste-
ric antagonists inhibit both affi   nity and avidity regulation of 
LFA-1, whereas      /      I  –  like allosteric antagonists inhibit only 
affi   nity regulation (  16  ). 
  The spatial regulation of LFA-1 activation is thought to 
play an important role in cell migration (  33  –  35  ). Recently, the 
human monoclonal antibody AL-57, which specifi  cally re-
cognizes the active conformation of the        L   I domain in a fashion 
that mimics physiological ligands, has been used to demon-
strate the activation of LFA-1 on human T lymphocytes surface 
(  32  ). We used this activation-dependent antibody to examine 
the eff  ect of MyH9 inhibition with blebbistatin on the spatial 
distribution of active LFA-1 on polarized T lymphocytes 
during migration. A nonfunction blocking and activation-
    Figure 4.         MyH9  –  LFA-1 association is not required for CXCL-12  –
  induced LFA-1 activation.   (A) T lymphocytes were stimulated with 
(fi  lled histograms) or without (open histograms) 100 ng/ml CXCL-12 for 
the indicated time period. Cells were labeled with KIM127 antibody and 
subjected to fl  ow cytometry. Experiments were performed in triplicate 
with cells from three different donors. Representative histograms show-
ing the time course of KIM127 epitope expression are shown. (B) Human 
T lymphocytes adherent to ICAM-1  –  coated slides were stimulated with 100 nM 
CXCL-12. Nonadherent cells were removed, and the number of bound 
cells was counted. Data are expressed as mean   ±   SEM of three experi-
ments. The experiment is representative of results from three independent 
donors. (C) Lysates obtained from CXCL-12  –  stimulated T lymphocytes 
were subjected to      L   (TS2/4 antibody) and      2   (CBR LFA-1/2 antibody) 
immunoprecipitation, and then to silver staining. Mouse IgG antibody 
served as a negative control. (D) T lymphocytes were pretreated with 
50      M blebbistatin or DMSO and analyzed as described above (A). A rep-
resentative result of three separate experiments is shown. (E) Data represent 
the mean instantaneous velocities of 10 representative T lymphocytes 
without (Control) or with 50      M blebbistatin (Blebbistatin), respectively, 
in a parallel-plate fl  ow chamber coated with CXCL-12 and ICAM-1 at a 
wall shear stress of 0.5 dyn/cm  2  . T lymphocyte trajectory was monitored 
for 2 s before the fi  rst contact between cells and substrate (arrow) and 
arrest (time 0). The time interval between data points is 33 ms. All data 
are expressed as mean   ±   SEM.     200 LFA-1 DE-ADHESION | Morin et al.
lymphocyte migration (  Fig. 6, A  , B, and D).   BIRT377 also 
blocked cell polarization and adhesion in the presence of bleb-
bistatin (  Fig. 6, A   and D). In contrast, XVA143 was only able to 
reduce the total cell length by ~50% in the presence of bleb-
bistatin (  Fig. 6 B  ). Time-lapse video microscopy revealed that 
XVA143 (Video S12) partially detached the front half of elon-
gated T lymphocytes in the presence of blebbistatin, whereas 
BIRT377 (Video S11) fully detached the elongated T lym-
phocytes (  Fig. 6 C  ). XVA143 also only partially reduced T 
lymphocyte binding to ICAM-1/CXCL-12 surfaces in the 
presence of blebbistatin (  Fig. 6 D  ). These results suggest that 
LFA-1 affi   nity regulation mainly mediates cell adhesion at the 
anterior of the polarized T lymphocytes, whereas avidity regula-
tion of LFA-1 predominantly mediates adhesion of the uropod. 
  To visualize the spatial organization of affi   nity regulation 
and avidity regulation at the cell  –  substrate contact, we per-
formed total internal refl  ection fl  uorescence (TIRF) imaging 
of KIM127, m24, and TS2/4 labeling. Because the epitopes of 
  In control T lymphocytes, both BIRT377 and XVA143 
(Video S11, available at http://www.jem.org/cgi/content/
full/jem.20071543/DC1) abolished cell polarization and in-
hibited adhesion to ICAM-1/CXCL-12 surfaces, suggesting 
that affi   nity regulation of LFA-1 is more critical in normal T 
    Figure 5.         MyH9  –  LFA-1 association is not required for the localiza-
tion of active LFA-1 at the leading edge.   (A) Human primary T lympho-
cytes were pretreated for 1 h with DMSO or 50      M blebbistatin, incubated 
on cover glasses coated with ICAM-1 and CXCL-12 for 30 min, and pro-
cessed for dual immunofl  uorescence labeling with AL-57 (green), an anti-
body specifi  c for the active human      L   I domain, and TS2/4 (red). Nuclei of 
blebbistatin-treated cells were counterstained with DAPI (blue). Bar, 20   μ  m. 
(B) T lymphocytes treated with DMSO, 50      M, or 200      M blebbistatin for 1 h 
were allowed to migrate on ICAM-1/CXCL-12  –  coated surfaces. DIC time-
lapse images were obtained at an acquisition rate of one frame per second. 
A narrow rectangular cursor was drawn on the time-lapse image stack 
(left, white line) so that the long axis of the rectangle was aligned with the 
direction of cell movement, which was determined by viewing the series as 
a movie. The rectangle was 4 pixels in width and long enough for complete 
motion analysis. This region of interest was then taken from each image in 
the time-lapse series, and the images were pasted side-by-side in a mon-
tage to form the kymograph picture. Each cycle of contractions was 
marked with white arrows (right). Bar, 10   μ  m. (C) T lymphocytes treated 
with DMSO (Con), 50      M, 100      M, or 200      M blebbistatin for 1 h were 
allowed to migrate on ICAM-1/CXCL-12  –  coated surfaces. The polarization 
index of cells was calculated as the ratio of x to y, where x is the longest 
distance across cells (from head to tail) and y is the greatest width perpen-
dicular to x. 30 cells for each group were analyzed.     
    Figure 6.         Uropodal adhesion depends on LFA-1 avidity regulation, 
and uropodal detachment is mediated by MyH9.   (A – C)  Human  T  lym-
phocytes were pretreated with DMSO or 50      M blebbistatin for 1 h and 
allowed to migrate on ICAM-1/CXCL-12  –  coated surfaces for 20 min. Then 
cells were treated with 20      M BIRT377, 1      M XVA143, or an equivalent 
concentration of DMSO for the indicated times. The cell polarization index 
was then determined. Data are expressed as mean   ±   SEM of three experi-
ments, each performed in triplicate. Representative DIC images from 
time-lapse movies are shown in C. (D) T lymphocytes were pretreated with 
DMSO or blebbistatin and allowed to settle on the ICAM-1/CXCL-12  –
  coated cover glasses for 20 min in L-15 plus 2 mg/ml glucose. Cells were 
then treated with 20      M BIRT377, 1      M XVA143, or DMSO. After removal 
of nonadherent cells from the cover glasses, bound cells were counted. 
Data are expressed as mean   ±   SEM of three experiments.     JEM VOL. 205, January 21, 2008 
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  DISCUSSION 
  The data presented here demonstrate that MyH9 associates 
with ICAM-1  –  bound LFA-1 in T lymphocytes and provides 
the critical force for rapid rupture of the bonds between LFA-1 
and ICAM-1 at the uropod during cell migration. MyH9 
association with LFA-1 is mainly involved in the tail detach-
ment from the ICAM-1 surface during migration, but is not 
directly related to LFA-1 activation. The overall strength of 
cellular adhesive interactions results from the combination of 
both the affi   nity of individual receptor  –  ligand bonds and the 
total number of bonds formed. According to Bell  ’  s theory (  43  ), 
although most individual cellular bonds are reversible, a me-
chanical force against a bond is required to separate the cells 
when many bonds exist between them (  “  avidity regulation  ”  ), 
and the mechanical force acting against a bond can increase 
the frequency of bond dissociation between the receptor and 
the bound ligand. Thus, as a cell migrates, its ability to detach 
its tail from the posterior contacts may depend on the cyto-
skeletal contractile force exerted against the bonds between 
the plasma membrane adhesion molecules and their ligands. 
Our fi  ndings support this theory and demonstrate that, as 
T lymphocytes migrate on ICAM-1 surfaces, the contact be-
tween the tail and the substrate is mediated by the   “  valency  ”   
of the interaction between low affi   nity LFA-1 and ICAM-1, 
and that subsequent detachment depends on the contractile 
force exerted by MyH9 on LFA-1. 
  MyH9 is one of three diff  erent isoforms of the heavy chain 
of type II nonmuscular myosin. Although MyH9 is clearly 
involved in cell migration and there have been many reports 
of myosin II localization at the posterior of migrating cells (  44  ), 
no studies have assessed the specifi  c role of MyH9 in integrin-
mediated cell adhesion and migration. Consistent with our 
fi  ndings in human T lymphocytes, a recent study in mouse 
lymphocytes has revealed that MyH9 is localized to the uropod 
(  45  ). In addition, inhibition of MyH9 dramatically reduced T 
lymphocyte motility and migration. The authors proposed 
that MyH9 inhibition reduces cell migration mainly by abol-
ishing cell polarization. In stark contrast, our study reveals that 
inhibition of MyH9 in human T lymphocytes induces an ex-
treme polarization as well as a defect in tail retraction, with the 
motility of the leading edge being only minimally aff  ected. This 
discrepancy may be due to the diff  erent sensitivity of mouse 
MyH9 to blebbistatin (  Fig. 5 C  ) or the diff  erent substrates used. 
In the aforementioned study, migration assays were performed 
mainly on plain cover glass, which lacks protein substrates 
required for cell migration. On the other hand, most of our 
experiments have been performed on ICAM-1, which is a highly 
specifi  c ligand for LFA-1. 
  The association between LFA-1 and MyH9 was demon-
strated by coimmunoprecipitation of endogenous proteins. 
This association occurs in response to LFA-1 binding to 
ICAM-1, but not in response to CXCL-12 stimulation. A di-
rect association between myosin and integrin has previously 
been reported (  46  ). Myo10, an unconventional myosin, binds 
directly to the NPXY motif of integrin       subunit cytoplas-
mic domains via its FERM (band 4.1/ezrin/radixin/moesin) 
KIM127 (  39  ) and m24 (  40  ) map to the EGF2 domain in the 
leg of        2   subunit and the activated        2   I  –  like domain, respec-
tively, they will recognize both ligand-bound and -unbound 
active conformations of LFA-1 and thus, are predicted to 
  detect affi   nity-regulated sites (  41  ). As we predicted, KIM127 
labeling was concentrated at the cell contact zone, predominantly 
at the anterior of the cell. Total LFA-1, as seen by labeling with 
the conformation nonselective antibody, TS2/4, was evenly 
distributed throughout the contact area (  Fig. 7 A  ).   Consistent 
with previous reports (  34, 42  ), no obvious m24 labeling was 
displayed at the uropod (  Fig. 7 B  ). These results suggest that 
LFA-1 at the posterior contact zone, which is not stained 
by KIM127 or m24, mediates cell adhesion without confor-
mational activation, probably through avidity regulation. 
    Figure 7.         High affi  nity LFA-1 is not required for uropodal adhesion.  
(A and B) Human primary T lymphocytes were pretreated with blebbistatin 
and incubated on cover glasses coated with ICAM-1 and CXCL-12 for 
20 min. Cells were then processed for dual immunofl  uorescent labeling with 
TS2/4 antibody and KIM127 (A) or m24 (B) antibody and subjected to TIRF 
microscopy. Ratio images were generated by subtracting the background 
and dividing KIM127 (A) or m24 (B) intensity by TS2/4 intensity. Line pro-
fi  les of LFA-1 intensity are presented along the front (Head)-to-back (Tail) 
line (A). (B) From three independent experiments, a total of 48 (KIM127/
TS2/4) and 35 (m24/TS2/4) cells was randomly selected, carefully ana-
lyzed, and scored for the presence of KIM127 or m24 staining enriched 
at the anterior region, the posterior region, or both, based on the ratio 
images. Each bar represents the percentage of total cells scored. The black 
portion of each bar is the fraction of cells scored for the anterior region 
dominant staining of KIM127 or m24. The white portion of each bar is the 
fraction of the cells that showed even distribution of staining. The gray 
portion of each bar is the fraction of cells scored for the posterior region 
dominant staining of KIM127 or m24. Bar, 20   μ  m.     202 LFA-1 DE-ADHESION | Morin et al.
detachment of T lymphocytes was further confi  rmed by in-
hibition of RhoA, which is an upstream activator of ROCK 
(  53  ). Phosphorylation of the myosin regulatory light chain 
(MLC) stimulates the actin-dependent ATPase activity of 
myosin II and promotes the fi  lament assembly. At least three 
kinases can phosphorylate MLC in vitro: myosin light chain 
kinase, ROCK, and p21-activated kinase (  24  ). Unlike other 
kinases, ROCK is mainly localized at the trailing edge during 
T lymphocyte migration, suggesting that it may play a major 
role in the signaling events responsible for MyH9 activation 
and LFA-1 de-adhesion. Therefore, it is tempting to specu-
late that LFA-1 outside-in signaling mediated by the RhoA  –
  ROCK pathway (  54  ) may impinge on MyH9 to regulate 
LFA-1 de-adhesion during T lymphocyte migration. Direct 
functional relation between MyH9 and ROCK in T lym-
phocytes is not currently known, but RhoA and its eff  ector 
kinase ROCK regulate MyH9 activity through MLC phos-
phorylation in platelet (  55  ). 
  We have previously found (  16  ) that       I  –   (BIRT377) and 
     /      I  –  like (XVA143) allosteric antagonists provide a useful 
means for distinguishing between affi   nity and avidity regulation 
of LFA-1 adhesiveness. Using these two classes of antagonists, 
we have demonstrated that LFA-1 affi   nity regulation occurs 
at the anterior of the polarized T lymphocyte, and LFA-1 
avidity regulation mainly works at the posterior to mediate 
cell adhesion during migration. The ability of XVA143 to 
inhibit T lymphocyte migration on ICAM-1 demonstrates 
that affi   nity regulation of LFA-1 is crucial for normal cell 
migration. In contrast, the inability of XVA143 to restore tail 
detachment in the presence of blebbistatin demonstrates that 
LFA-1  –  ICAM-1 interactions at the tail of migrating T lympho-
cytes are not subject to affi   nity regulation. 
  The lack of affi   nity regulation (active conformation) of 
LFA-1 at the tail adhesion was also confi  rmed by TIRF mi-
croscopy of KIM127 and m24 labeling. Binding of ligands to 
the extracellular domains of integrins initiates intracellular sig-
naling (outside-in signal) and induces conformational changes 
in both the extracellular and the cytoplasmic domains. These 
conformational changes are predicted to be similar to those 
induced by inside-out signals. Therefore, because KIM127 
and m24 recognize the EGF2 domain in the leg of the        2   sub-
unit and the activated        2   I  –  like domain, respectively, it is also 
likely that they recognize both ligand-bound and -unbound 
active conformations of LFA-1. Both ligand-bound and -un-
bound active LFA-1, as identifi  ed by KIM127 and m24, are 
primarily located at the anterior of the cell body, but less at the 
posterior. Also, the        L   I domain antibody AL-57 revealed that 
a small population of ICAM-1  –  unoccupied active LFA-1 is 
exclusively located at the tip of the leading edge. Collectively, 
our results support the hypothesis that high affi   nity LFA-1 
forms a stable adhesion in the front area of migrating T lym-
phocytes and switches to a low affi   nity conformation upon 
reaching the uropod, where it maintains adhesion through 
avidity regulation. Moreover, MyH9 is critical for generating 
suffi   cient pulling force to detach LFA-1 from ICAM-1 at the 
tail and to retract the uropod. 
domain (  46  ). Overexpression of Myo10 results in the for-
mation of elongated fi  lopodia due to the transport of excess 
integrins to the tips of fi  lopodia. Unlike Myo10, MyH9 does 
not contain any known integrin-binding motifs in its tail 
domain. Therefore, it is possible that association of MyH9 
with LFA-1 may require adaptor molecules. Interestingly, 
the LFA-1  –  MyH9 complex also contains      -actin (  Fig. 1 B  ). 
Although it is currently unclear whether there are addi-
tional proteins in the complex, it is tempting to speculate that 
     -actin binds to LFA-1 through adaptor molecules such as 
talin (  9, 47, 48  ), and activated MyH9 binds to the LFA-1  –
       -actin complex to exert the mechanical force necessary for 
LFA-1 detachment. 
  Blebbistatin was originally discovered in a screen for in-
hibitors of nonmuscle myosin II (  28  ). Blebbistatin, a noncom-
petitive myosin II inhibitor, functions by binding the large 
cleft in the motor domain, which opens and closes during the 
contractile cycle. Binding of blebbistatin to myosin II results 
in a long-lived complex of myosin with ADP and inorganic 
phosphate. The formation of this complex precedes the force-
generating step, which is catalyzed by the release of phosphate 
upon the rebinding of myosin with actin. Thus, blebbistatin 
inhibits the transition into force-producing states (  49  ). There-
fore, the elongated tail and the defects in tail detachment seen 
in blebbistatin-treated T lymphocytes on ICAM-1 may sim-
ply be due to down-regulation of the cytoskeletal traction 
force that is required for tail contraction. The concentration 
of blebbistatin used here (50      M) did not totally abolish tail 
contraction; however, BIRT377 co-treatment caused the 
elongated T lymphocytes to quickly contract their tails and 
round up (  Fig. 6, A and C,   and Video S10). These results sug-
gest the presence of both a blebbistatin-resistant cellular con-
traction force and a blebbistatin-sensitive LFA-1 detachment 
force at the posterior of migrating T lymphocytes. 
  Surface particle tracking measurements on wild-type and 
mutant   Dictyostelium   lacking myosin II suggest that a myosin 
II  –  based force predominates at the posterior of the cell (  50  ). 
Myosin II  –  mediated cell contractility is also implicated in ad-
hesion, protrusion, and actin organization at the leading edge, 
especially in slow migrating cells (  51  ). There are numerous 
reports that myosin II contraction is a key regulator of adhe-
sion maturation and actin organization at the anterior of cells 
(  51, 52  ). Compared with the dramatic eff  ects of 50      M bleb-
bistatin at the tail of migrating T lymphocytes, the eff  ects of 
myosin II inhibition at the leading edge require higher con-
centrations of blebbistatin (  Fig. 5   and Video S9). Based on 
this, we conclude that, in fast migrating T lymphocytes, the 
cellular contraction force generated at the anterior of the cell 
is less sensitive to blebbistatin, and that MyH9 provides a 
blebbistatin-dependent detachment force at the tail. 
  Inhibition of ROCK in human T lymphocytes resulted 
in similar cell morphology as we have seen in our T lympho-
cyte migration assay in the presence of blebbistatin, showing 
extreme tail elongation (  53  ). Like the inhibition of MyH9, 
ROCK inhibition had no eff  ect on the T lymphocyte adhe-
sion on ICAM-1. Involvement of ROCK activity in the tail JEM VOL. 205, January 21, 2008 
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PVDF membrane (Bio-Rad Laboratories). Membranes were probed with 
primary antibodies and appropriate peroxidase-conjugated secondary antibody. 
Immunoreactive bands were visualized by chemiluminescence. 
  Migration assay.     Delta T dishes (Thermo Fisher Scientifi  c) were coated 
with 6   μ  g/ml of human tonsil ICAM-1 and 2   μ  g/ml CXCL-12 (suspended 
in 20 mM Tris, pH 9, 159 mM NaCl, and 2 mM MgCl  2  ) for 12 h at 4  °  C and 
for 4 h at room temperature. To inhibit MyH9, primary T lymphocytes were 
incubated with 50      M blebbistatin for 1 h or transfected with MyH9 siRNA. 
Either DMSO (1:1,000) or nontargeting siRNA served as a control. Approx-
imately 5   ×   10  4   T lymphocytes were washed and added to the delta T dish 
containing 1 ml of L-15 medium with 2 mg/ml glucose   ±   blebbistatin. Bright 
fi  eld or DIC images were acquired every second or every 5 s for 30 min 
under a 20  ×   objective lens using MetaVue software. The temperature was 
maintained at 37  °  C throughout the experiment. Migration was analyzed by 
tracing the movement of individual cells in video using Image J software. 
  Assay of cell adhesion to ICAM-1.     In vitro dynamic cell adhesion assays 
were performed as reported previously (  56, 57  ). In brief, cells were resus-
pended at 10  7  /ml in L-15 medium containing 2 mg/ml glucose. Adhesion 
assays were performed on 18-well glass slides. Slides were coated with purifi  ed 
human tonsil ICAM-1 (1   μ  g/ml in 20 mM Tris, pH 9, 150 mM NaCl, and 
2 mM MgCl  2  ) overnight at 4  °  C and for 4 h at room temperature. They were 
then blocked with 2% BSA at 37  °  C. 5      l of cell suspension was added to each 
well, and cells were stimulated at 37  °  C with 5   μ  l of 200 nM CXCL-12. Cells 
were then washed and fi  xed, and the number of bound cells was quantifi  ed. 
  Flow chamber assay was performed in a rectangular parallel-plate fl  ow 
chamber (GlycoTech) with a gasket (0.25 cm wide, 127 mm thick, and 2 cm 
long). Polystyrene Petri dishes (diameter, 35 mm; Falcon 1008) enclosed 
using a single-well fl  exiPERM (Sigma-Aldrich) were coated with a mixed 
solution of 10   μ  g/ml Purifi  ed Recomb Protein A/G (Thermo Fisher Scientifi  c) 
and 1   μ  g/ml CXCL-12 at room temperature for 2 h. The surfaces were then 
washed with 1% BSA in PBS. 5   μ  g/ml ICAM-1/Fc (R  &  D Systems) was ap-
plied to the surfaces and allowed to bind the protein A/G  –  coated surfaces at 
room temperature for 2 h. The surfaces were then blocked for nonspecifi  c 
adhesion with 2% BSA in PBS at 4  °  C for overnight. Before the fl  ow chamber 
experiments, the dishes were washed with prewarmed L-15 medium (37  °  C). 
The fl  ow chamber was mounted on an inverted microscope (IX81; Olym-
pus) and a microscope stage top incubator (LiveCell2; Pathology Devices) 
was installed on the fl  ow chamber to perform the fl  ow chamber experiments 
at 37  °  C. 10  6  /ml T lymphocytes were prewarmed in L-15 medium at 37  °  C 
and perfused into the chamber using a syringe pump (New Era Pump Sys-
tems Inc.) at a fl  ow rate corresponding to a calculated wall shear stress of 
0.5 dyn/cm  2  . To investigate the eff  ect of blebbistatin, T lymphocytes were 
incubated with 50      M blebbistatin at 37  °  C for 1 h before experiments. Arrest 
of T lymphocytes on immobilized ICAM-1 was observed in the fi  eld of view 
of 864   ×   648      m  2   using bright fi  eld microscopy under a 10  ×   objective (NA, 
0.30; Plan Fluorite; Olympus) with a microscope-linked CCD camera (KP-
M1AN; Hitachi). Cell adhesion videos were redigitalized to 640   ×   480 pixels 
at 29.97 fps with ff  mpegX software. The stacked images were thresholded 
and de-interlaced, and the coordinates of the centroid of interacting T lym-
phocytes with immobilized ICAM-1 were then acquired using ImageJ 1.39a 
(National Institutes of Health [NIH]). To overlay the cell trajectories, the 
earliest time when each cell rolled slower than 5      m/s was set to zero. 
  Fluorescence microscopy.     Coverslips were prepared as described for im-
munoprecipitation experiments. T lymphocytes were washed, resuspended 
in L-15 medium containing 2 mg/ml glucose, and incubated on the cover 
glass for 20 min at 37  °  C. Cells were transferred to room temperature, fi  xed 
(3.7% formaldehyde in PBS for 10 min), and blocked with 10% FBS over-
night. Cells were labeled with 10      g/ml AL-57 IgG for 1 h, followed by a 
1-h incubation with 10   μ  g/ml anti-       L   monoclonal antibody (TS2/4). Cells 
were then incubated with Cy3-conjugated anti  –  mouse Ig (Invitrogen) and 
FITC-conjugated anti  –  human Ig (Invitrogen) for 20 min, and then washed 
three times with PBS. Image acquisition was conducted on an epifl  uorescence 
  MATERIALS AND METHODS 
  Materials.     The small molecule LFA-1 inhibitor XVA143 was provided by 
P. Gillespie (Roche). The inhibitor BIRT377 was from Boehringer Ingel-
heim Pharmaceuticals Inc. The source for anti  –  human        L   monoclonal anti-
body TS2/4 has been described previously (  39  ). The monoclonal antibody 
m24 was provided by N. Hogg (London Research Institute, London, UK). 
KIM127 monoclonal antibody was prepared from hybridoma (American 
Type Culture Collection). Monoclonal antibody to      -actin was from Ab-
cam, and MyH9 antibody was from Covance. Blebbistatin was purchased 
from Sigma-Aldrich. 
  Cell culture.     PBMCs were separated from 50 ml of whole blood by His-
topaque (Sigma-Aldrich) density gradient centrifugation. Lymphocytes were 
cultured for 3 d in RPMI 1640 containing 10% FBS and 1   μ  g/ml PHA (Remel). 
Lymphocytes were then cultured in the presence of 10 ng/ml IL-15 (R  &  D 
Systems) for 4  –  7 d. These cells were 97% CD3  +   and CD56         as determined 
by fl  ow cytometry (  16  ). The Human Research Studies Review Board of the 
University of Rochester approved this study. 
  RT-PCR.     Total RNA was prepared from PBMCs and a T lymphocyte 
RNeasy mini kit (QIAGEN). Isolated mRNA was reverse transcribed and 
amplifi  ed by PCR in one step using a QIAGEN One-Step RT-PCR kit 
with the following sense and antisense primers: MyH9: sense, gaagagctagag-
gcgctgaa; antisense, ctttgccttctcgaggtttg; MyH10: sense, gtaccttgcccatgttgctt; 
antisense, ttttgcttgacgaacagcac; and MyH14: sense, ccagaatcgggaaagtgaaa; 
antisense, ctcctcctccagctcttcct. 
  siRNA.     A pool (SMARTpool) of siRNAs specifi  c for human MyH9 and 
Cy3-conjugated RISC-free control siRNAs were synthesized by Dharma-
con. Primary T lymphocytes were transfected using the AMAXA Nucleo-
fector system (Program T-14). Cultures were transfected with 0.15   μ  g 
Cy3-conjugated RISC-free control siRNA   ±   1.45   μ  g MyH9 siRNA. After 
transfection, cells were cultured for 18 h in IL-15  –  containing media (RPMI 
1640, 10% FBS, 10 ng/ml IL-15). Cy3 fl  uorescent cells were considered to 
be MyH9 siRNA cotransfectants. 
  FACS analysis.     2   ×   10  6   primary T lymphocytes were treated with 50      M 
blebbistatin or a 1:1,000 dilution of DMSO for 1 h at 37  °  C, and then stimu-
lated with 100 ng/ml CXCL-12 (R  &  D Systems) for 0, 2, 5, 10, 15, or 20 min. 
Cells were fi  xed with an equal volume of 2  ×   formaldehyde (7.4%) and in-
cubated with 4   μ  g/ml KIM127 antibody for 30 min. After thorough wash-
ing, cells were then incubated with R-phycoerythrin  –  conjugated donkey 
anti  –  mouse IgG antibody (1:100; BD Biosciences). Mean fl  uorescence in-
tensity was determined using a Becton Dickinson FACS Array system and 
WinMDI 2.8 software. 
  Immunoprecipitation.     Cover glasses were coated with 6   μ  g/ml of human 
tonsil ICAM-1 or 10   μ  g/ml poly-  l   lysine in the presence or absence of 2   μ  g/ml 
CXCL-12 (suspended in 20 mM Tris, pH 9, 159 mM NaCl, and 2 mM MgCl  2  ). 
Coatings were performed at 4  °  C for 12 h, followed by 4 h at room tempera-
ture. T lymphocytes (5   ×   10  6  /500   μ  l) were washed and resuspended in L-15 
medium (Invitrogen) containing 2 mg/ml glucose or in 20 mM Hepes, 150 mM 
NaCl, 5 mM MgCl  2  , 1 mM EGTA, and 2 mg/ml glucose. They were then 
incubated at 37  °  C for 20 min on the coated cover glass. Cells were lysed in 
cold buff  er containing HBSS, 2% Triton X-100, 120 mM   N  -octyl      -  d  -glu-
copyranoside, and EDTA-free mini-protease inhibitor cocktail (Roche). Insolu-
ble cell debris was removed by centrifugation. Lysates were then precleared 
with 2   μ  g mouse IgG isotype control antibody and protein G agarose beads 
(Invitrogen) for 30 min at 4  °  C. Immunoprecipitation was performed by in-
cubating lysates with protein G agarose and 14   μ  g TS2/4 or CBR LFA1/2 
antibody for 2 h at 4  °  C. Beads were thoroughly washed, suspended in 30   μ  l 
Laemmli buff  er, and boiled for 5 min. 5      l of each sample was separated on 
a 4  –  12% gradient gel (Cambrex), and the gel was silver stained using a Silver 
Quest kit (Invitrogen). Species of interest were excised, destained, and analyzed 
by mass spectrometry. For immunoblotting, proteins were transferred to 204 LFA-1 DE-ADHESION | Morin et al.
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microscope (TE2000-U microscope; Nikon), using a 60  ×   oil objective cou-
pled to a CoolSNAP HQ CCD (Roper Scientifi  c). 
  TIRF microscopy.     TIRF imaging was performed with a white light TIRF 
aperture diaphragm coupled to a microscope (TE2000-S; Nikon) and a 100  ×   
TIRF 1.49 NA oil immersion objective. All image processing was performed 
with MetaVue and Metamorph software (Molecular Devices). Cellular staining 
was performed as described above using 10   μ  g/ml of monoclonal antibody 
fl  uorescent conjugates, KIM127 Alexa 546, and TS2/4 Alexa 488. Alternatively, 
cells were stained using 10   μ  g/ml of m24 antibody in conjunction with Cy-3 
goat anti  –  mouse IgG and TS2/4 Alexa 488. 
  Online supplemental material.     In Video S1, time-lapse video micros-
copy of human T lymphocyte migration on poly-  l  -lysine in the presence 
of Mg  2+ /EGTA (1 sec video = 2.5 min real time) is shown. Video S2 fea-
tures time-lapse video microscopy of human T lymphocyte migration on 
ICAM-1 in the presence of Mg  2+ /EGTA (1 sec video = 2.5 min real time). 
Video S3 shows time-lapse video microscopy of human T lymphocyte 
migration on poly-  l  -lysine/CXCL-12 surface (1 sec video = 2.5 min real 
time). In Video S4, time-lapse video microscopy of human T lymphocyte 
migration on ICAM-1/CXCL-12 surface (1 sec video = 2.5 min real time) 
is shown. In Video S5, a time-lapse movie shows GFP intensity (highest 
[red] to lowest [blue]) of a MyH9-GFP–transfected human T lymphocyte 
migrating on ICAM-1/CXCL-12. The time scale of each frame is 30 sec. 
Video S6 is a time-lapse movie showing GFP intensity (highest [red] to 
lowest [blue]) of a       actin-GFP–transfected human T lymphocyte migrat-
ing on ICAM-1/CXCL-12. The time scale of each frame is 30 sec. Videos 
S7 and S8 feature time-lapse video microscopy of a blebbistatin (50      M; 
Video S7) or DMSO (1:1,000 dilution; Video S8) -treated human T lym-
phocyte migrating on ICAM-1/CXCL-12 surface (1 sec video = 2.5 min 
real time). Video S9 shows a high-resolution (60× objective + 1.5× zoom) 
movie of a blebbistatin (50      M) -treated human T lymphocyte migrating 
on ICAM-1/CXCL-12 surface. Time scale of each frame is 1 sec. In Video 
S10, time-lapse video microscopy shows inhibition of T lymphocyte migra-
tion on ICAM-1/CXCL-12 by XVA143 (1 sec video = 2.5 min real time). 
XVA143 was added during the interval of the movie. In Video S11, time-
lapse video microscopy shows inhibition of a blebbistatin-treated human T 
lymphocyte migrating on ICAM-1/CXCL-12 by BIRT377 (1 sec video = 
2.5 min real time). BIRT377 was added during the interval of the movie. 
In Video S12, time-lapse video microscopy shows partial inhibition of a 
blebbistatin-treated human T lymphocyte migrating on ICAM-1/CXCL-12 
by XVA143 (1 sec video = 2.5 min real time). XVA143 was added during 
the interval of the movie. Videos S1–S12 are available at http://www.jem
.org/cgi/content/full/jem.20071543/DC1.
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